Lawmakers cross-examined pharmacy benefit manager (PBM) representatives during a Congressional hearing; the proportion of hospital inpatients covered by private Medicare Advantage (MA) plans is rapidly increasing; public health officials are concerned after poliovirus was found in sewage samples from Gaza.
Lawmakers concerned about high drug prices questioned representatives from pharmacy benefit managers (PBMs) during a Congressional hearing Tuesday, according to The Hill. PBMs’ job is to negotiate drug prices, manage pharmacy networks, and influence which medications patients can access. The industry blames drug companies for high prices, claiming they save patients money through negotiations. Lawmakers, however, are skeptical. A committee report suggests PBMs favor expensive drugs with high rebates, potentially steering patients away from cheaper alternatives. They also control a large share of the market and may incentivize using their own mail-order pharmacies over independent ones. Independent pharmacists argue these practices threaten their businesses. The Federal Trade Commission also recently raised concerns about anticompetitive behavior by PBMs. The hearing reflects growing pressure on PBMs, which lawmakers might use to push for reforms in upcoming legislation.
The number of hospital patients covered by private Medicare Advantage (MA) plans is rapidly increasing, according to Axios. This trend is causing tension between hospitals and insurers. Hospitals argue that MA plans pay lower rates and create administrative burdens by denying claims or requiring preapproval for care. This can lead to financial strain for hospitals and potentially higher costs for patients. As the number of MA enrollees grows, so does the power of insurers. Lawmakers are considering ways to address these issues, such as requiring faster review times for treatment approvals by MA plans.
Public health officials are alarmed after poliovirus was found in sewage samples from Gaza, according to NBC News. The war-struck region has a crumbling health care system and poor sanitation, making it highly vulnerable to an outbreak. Vaccinations rates have dropped in Gaza, leaving many children unprotected as well. Humanitarian groups are scrambling to deliver vaccines and assess the scope of the problem. Experts have warned that time is critical as the virus could spread quickly in these conditions.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Cutting-Edge Eye Care Technologies Highlighted at SECO 2025
February 28th 2025Artificial intelligence, surgical innovations, and wearable technology are transforming eye care, enhancing patient outcomes and clinical efficiency, as discussed during the keynote presentation at the Southeastern Congress of Optometry (SECO) 2025.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Understanding SMA Subtypes and the Impact of Treatment Advances
February 28th 2025The classification of spinal muscular atrophy (SMA) subtypes, the influence of SMN2 gene copies on disease severity, treatment effects on disease progression, age-related differences, long-term management strategies, and adequate muscle function monitoring are all important aspects of SMA care.
Read More